乳腺癌组织学对超声与病理肿瘤大小测量之间关系的影响。

Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements.

作者信息

Pritt Bobbi, Ashikaga Takamaru, Oppenheimer Robert G, Weaver Donald L

机构信息

Department of Pathology, University of Vermont College of Medicine, Burlington, VT 05405-0068, USA.

出版信息

Mod Pathol. 2004 Aug;17(8):905-10. doi: 10.1038/modpathol.3800138.

Abstract

Establishing an accurate primary invasive breast cancer size is crucial for patient management. Although ultrasonographic measurement is reported to correlate reliably with the gold standard pathology measurement, few authors have examined the influence of histologic subtype on ultrasound measurement. The common subtypes of invasive breast carcinoma, ductal and lobular, have different growth patterns, which may influence the ability of ultrasound to predict pathologic size. For this analysis, ultrasound and pathology reports were retrospectively reviewed for 204 women with 210 invasive breast cancers, including 129 ductal, 41 lobular, and 40 mixed pattern ductal and lobular carcinomas. For each tumor, the largest pathology and ultrasound dimensions were compared using Pearson's correlations, linear regression, paired t-tests and Wilcoxon signed ranks tests, stratified by histologic subtype. The Hodges-Lehmann approach was used to obtain 95% confidence intervals (CI) for median difference of the sizes. Ultrasonography consistently underestimated pathologic tumor size; the overall median difference was 3.5 mm (CI: 2.5-4.0 mm) and for subtypes: 2.5 mm (CI: 1.5-3.5 mm) for ductal pattern; 3.0 mm (CI: 1.5-4.5 mm) for mixed pattern; and in contrast, 7.5 mm (CI: 5.0-13.5 mm) for lobular pattern tumors. Significant correlations of similar magnitude, were observed between size measurements for ductal, lobular, and mixed subtypes (r=0.816, 0.811 and 0.672, respectively; all P<0.001); however, linear regression models differed between subtypes. Although practical and widely available, ultrasonography tends to underestimate pathologic tumor size. The size difference may be large for lobular carcinomas, potentially influencing stage; differences are less pronounced for ductal and mixed subtypes. Pathologic tumor size can be estimated from the ultrasonographic measurement, particularly if the histologic tumor subtype is known. The results of this study underscore the continued benefit of pretreatment tumor histology.

摘要

确定原发性浸润性乳腺癌的准确大小对于患者管理至关重要。尽管据报道超声测量与金标准病理测量有可靠的相关性,但很少有作者研究组织学亚型对超声测量的影响。浸润性乳腺癌的常见亚型,导管癌和小叶癌,具有不同的生长模式,这可能会影响超声预测病理大小的能力。在本分析中,对204名患有210例浸润性乳腺癌的女性的超声和病理报告进行了回顾性审查,其中包括129例导管癌、41例小叶癌和40例导管和小叶混合型癌。对于每个肿瘤,使用Pearson相关性、线性回归、配对t检验和Wilcoxon符号秩检验比较最大病理尺寸和超声尺寸,并按组织学亚型分层。采用Hodges-Lehmann方法获得大小中位数差异的95%置信区间(CI)。超声检查一直低估了病理肿瘤大小;总体中位数差异为3.5毫米(CI:2.5 - 4.0毫米),各亚型情况如下:导管型为2.5毫米(CI:1.5 - 3.5毫米);混合型为3.0毫米(CI:1.5 - 4.5毫米);相比之下,小叶型肿瘤为7.5毫米(CI:5.0 - 13.5毫米)。在导管型、小叶型和混合型亚型的大小测量之间观察到相似程度的显著相关性(分别为r = 0.816、0.811和0.672;均P < 0.001);然而,各亚型的线性回归模型有所不同。尽管超声检查实用且广泛可用,但它往往会低估病理肿瘤大小。小叶癌的大小差异可能很大,可能影响分期;导管型和混合型亚型的差异不太明显。病理肿瘤大小可以根据超声测量来估计,特别是如果已知组织学肿瘤亚型。本研究结果强调了治疗前肿瘤组织学的持续益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索